Boston Family Office LLC Purchases 166 Shares of Waters Co. (NYSE:WAT)

Boston Family Office LLC boosted its position in shares of Waters Co. (NYSE:WAT) by 22.0% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 922 shares of the medical instruments supplier’s stock after buying an additional 166 shares during the period. Boston Family Office LLC’s holdings in Waters were worth $332,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Kennebec Savings Bank bought a new position in Waters during the third quarter valued at approximately $33,000. Ashton Thomas Securities LLC purchased a new stake in Waters during the third quarter valued at approximately $35,000. Itau Unibanco Holding S.A. purchased a new stake in Waters during the second quarter valued at approximately $33,000. Blue Trust Inc. raised its position in Waters by 190.2% during the second quarter. Blue Trust Inc. now owns 119 shares of the medical instruments supplier’s stock valued at $35,000 after purchasing an additional 78 shares during the period. Finally, TFC Financial Management Inc. raised its position in Waters by 19,900.0% during the second quarter. TFC Financial Management Inc. now owns 200 shares of the medical instruments supplier’s stock valued at $58,000 after purchasing an additional 199 shares during the period. 94.01% of the stock is owned by institutional investors.

Waters Stock Up 1.3 %

Shares of NYSE WAT opened at $378.48 on Tuesday. The company has a current ratio of 2.02, a quick ratio of 1.38 and a debt-to-equity ratio of 1.14. The stock has a market capitalization of $22.47 billion, a PE ratio of 36.11, a price-to-earnings-growth ratio of 6.83 and a beta of 0.97. The stock’s fifty day simple moving average is $355.03 and its two-hundred day simple moving average is $332.34. Waters Co. has a 12-month low of $273.60 and a 12-month high of $393.38.

Waters (NYSE:WAT) last announced its earnings results on Friday, November 1st. The medical instruments supplier reported $2.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.68 by $0.25. The business had revenue of $740.30 million for the quarter, compared to analysts’ expectations of $712.99 million. Waters had a return on equity of 49.93% and a net margin of 21.43%. The business’s revenue for the quarter was up 4.0% on a year-over-year basis. During the same quarter last year, the firm earned $2.84 EPS. As a group, analysts expect that Waters Co. will post 11.79 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

WAT has been the topic of a number of recent research reports. JPMorgan Chase & Co. upped their price objective on Waters from $340.00 to $380.00 and gave the company a “neutral” rating in a research report on Monday, November 4th. Cfra set a $389.00 price target on Waters in a report on Thursday, October 17th. TD Cowen increased their price target on Waters from $363.00 to $410.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Stifel Nicolaus increased their price target on Waters from $332.00 to $360.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Finally, Barclays raised their price objective on Waters from $330.00 to $360.00 and gave the stock an “underweight” rating in a report on Monday, November 4th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $365.85.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.